Trademark: 90289181
Word
STELLA
Status Date
Friday, August 9, 2024
Filing Date
Friday, October 30, 2020
9 Downloadable computer software and downloadable software applications for the provision of menopause care and support, namely, providing evidence and research based programmes, advice and digital therapeutics for the improvement and treatment of symptoms of menopause; computer software and downloadable software applications for helping manage menopause symptoms, namely, providing evidence and research based programmes, advice and digital therapeutics for the management of symptoms of menopause; downloadable computer communications software and downloadable communications software applications for instant messaging and for electronically exchanging data, audio, video images and graphics via computer, mobile, wireless, telecommunications networks and downloadable computer software for processing images, graphics, audio, video, and text; computer software and downloadable software applications related to the improvement and prevention of later life health conditions in women through evidence and research based programmes, advice and digital therapeutics; none of the foregoing including a virtual assistant that uses natural language understanding, voice recognition, or speech synthesis functionalities
44 Medical, healthcare and therapeutic services for the management, improvement and treatment of symptoms of menopause; provision of medical and healthcare advisory and consultancy services; provision of advisory and consultancy services related to therapeutic treatments; provision of medical, healthcare and therapeutic treatment information and resources; provision of information and resources in the field of women's health and wellness by downloadable mobile application and via a website; provision of information and resources relating to the improvement and prevention of later life health conditions in women by downloadable mobile application and via a website; provision of evidence-based medical, healthcare and therapeutic programmes and support; provision of research and data-based medical, healthcare and therapeutic programmes and support; all of the aforesaid related to menopause care and support, the management of menopause symptoms, and the improvement and prevention of later life health conditions in women; providing information, advisory and consultancy services related to the aforesaid
10 Medical devices for the provision of menopause care and support, namely, medical devices for the management, improvement and treatment of symptoms of menopause; medical devices for the improvement and prevention of later life health conditions in women, namely, medical devices to improve and prevent conditions such as osteoporosis, dementia, cardiovascular disease and diabetes
Nov 3, 2020
New Application Entered
Dec 26, 2020
New Application Office Supplied Data Entered
Feb 26, 2021
Teas Voluntary Amendment Received
Feb 26, 2021
Teas Amendment Entered Before Attorney Assigned
Apr 9, 2021
Non-Final Action E-Mailed
Apr 2, 2021
Assigned To Examiner
Apr 9, 2021
Non-Final Action Written
Apr 9, 2021
Notification Of Non-Final Action E-Mailed
Jun 6, 2022
Report Completed Suspension Check Case Still Suspended
May 18, 2021
Correspondence Received In Law Office
May 19, 2021
Teas/Email Correspondence Entered
May 18, 2021
Teas Response To Office Action Received
Jun 3, 2021
Suspension Letter Written
Jun 3, 2021
Letter Of Suspension E-Mailed
Jun 3, 2021
Notification Of Letter Of Suspension E-Mailed
Dec 6, 2021
Report Completed Suspension Check Case Still Suspended
Dec 9, 2022
Report Completed Suspension Check Case Still Suspended
Aug 3, 2023
Suspension Inquiry Written
Aug 3, 2023
Inquiry To Suspension E-Mailed
Aug 3, 2023
Notification Of Inquiry As To Suspension E-Mailed
Nov 2, 2023
Application Extension Granted/Receipt Provided
Jun 24, 2024
Correspondence Received In Law Office
Jun 28, 2023
Suspension Checked - To Attorney For Action
Nov 2, 2023
Application Extension To Response Period - Received
Jan 26, 2024
Teas Response To Suspension Inquiry Received
Jun 24, 2024
Teas/Email Correspondence Entered
Jun 24, 2024
Assigned To Lie
Aug 9, 2024
Final Refusal E-Mailed
Aug 9, 2024
Final Refusal Written
Aug 9, 2024
Notification Of Final Refusal Emailed
Trademark Alertz updated from USPTO on 2030-01-24
